May 14, 2026 10:35AM
May 14, 2026 10:35AM
Apr 22, 2026 08:04AM
Apr 22, 2026 08:00AM
Mar 18, 2026 08:02AM
Mar 18, 2026 08:00AM
Mar 12, 2026 08:00AM Incannex advances sleep apnea drug with new phase 2 study
Mar 12, 2026 08:00AM
Jan 29, 2026 08:00AM
Jan 29, 2026 08:00AM
Jan 14, 2026 08:00AM
Dec 3, 2025 08:00AM
Dec 3, 2025 08:00AM
Nov 20, 2025 09:34AM Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026
Oct 30, 2025 08:00AM
Aug 26, 2025 08:00AM
Aug 26, 2025 08:00AM
Aug 8, 2025 08:00AM
Aug 8, 2025 08:00AM
Jul 30, 2025 08:00AM
Jul 30, 2025 08:00AM Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X
Jun 12, 2025 07:30AM
May 29, 2025 07:30AM
May 29, 2025 07:30AM
May 28, 2025 07:00AM
May 28, 2025 07:00AM
May 15, 2025 08:00AM
May 14, 2025 08:00AM Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)
Apr 3, 2025 07:30AM
Feb 14, 2025 07:30AM
Jan 23, 2025 07:30AM
Jan 23, 2025 07:30AM
Dec 2, 2024 04:48PM
Nov 14, 2024 04:05PM
Oct 24, 2024 07:30AM Incannex Healthcare (IXHL) Appoints Lou Barbato as Chief Medical Officer
Oct 24, 2024 07:30AM
Oct 2, 2024 04:50PM
Sep 30, 2024 04:01PM
Sep 9, 2024 08:00AM
Aug 5, 2024 07:30AM
Jul 30, 2024 07:30AM
May 30, 2024 07:30AM Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
May 7, 2024 07:31AM
May 7, 2024 07:30AM
Apr 16, 2024 08:11AM
Apr 16, 2024 08:00AM
Feb 28, 2024 07:58AM
Feb 28, 2024 07:30AM
Feb 28, 2024 07:30AM Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
Feb 16, 2024 07:31AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All